Maturation and Endosomal Targeting of β-Site Amyloid Precursor Protein-cleaving Enzyme
暂无分享,去创建一个
R. Doms | J. Huse | V. Lee | G. Leslie | D. S. Pijak
[1] G. Multhaup,et al. Maturation and Pro-peptide Cleavage of β-Secretase* , 2000, The Journal of Biological Chemistry.
[2] M. Citron,et al. Expression Analysis of BACE2 in Brain and Peripheral Tissues* , 2000, The Journal of Biological Chemistry.
[3] J. Tang,et al. Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[4] D. Selkoe,et al. The Transmembrane Aspartates in Presenilin 1 and 2 Are Obligatory for γ-Secretase Activity and Amyloid β-Protein Generation* , 2000, The Journal of Biological Chemistry.
[5] A Helenius,et al. Setting the standards: quality control in the secretory pathway. , 1999, Science.
[6] Alfredo G. Tomasselli,et al. Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity , 1999, Nature.
[7] R. Barbour,et al. Purification and cloning of amyloid precursor protein β-secretase from human brain , 1999, Nature.
[8] David G. Tew,et al. Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase , 1999, Molecular and Cellular Neuroscience.
[9] S. Sisodia. Alzheimer's disease: perspectives for the new millennium. , 1999, The Journal of clinical investigation.
[10] J. Treanor,et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. , 1999, Science.
[11] M. Frosch,et al. Presenilin 1 Facilitates the Constitutive Turnover of β-Catenin: Differential Activity of Alzheimer’s Disease–Linked PS1 Mutants in the β-Catenin–Signaling Pathway , 1999, The Journal of Neuroscience.
[12] Sarah Tomlin,et al. Microtechnology: Laying it on thick , 1999, Nature.
[13] D. Selkoe,et al. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity , 1999, Nature.
[14] C. Pitcher,et al. Cluster of differentiation antigen 4 (CD4) endocytosis and adaptor complex binding require activation of the CD4 endocytosis signal by serine phosphorylation. , 1999, Molecular biology of the cell.
[15] R. Rozmahel,et al. Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of β-catenin,a component of the presenilin protein complex , 1999, Nature Medicine.
[16] Hans Clevers,et al. Destabilization of β-catenin by mutations in presenilin-1 potentiates neuronal apoptosis , 1998, Nature.
[17] P. Fraser,et al. The Presenilin 1 Protein Is a Component of a High Molecular Weight Intracellular Complex That Contains β-Catenin* , 1998, The Journal of Biological Chemistry.
[18] R. Doms,et al. Detection of a Novel Intraneuronal Pool of Insoluble Amyloid β Protein that Accumulates with Time in Culture , 1998, The Journal of cell biology.
[19] L. Kasturi,et al. The amino acid following an asn-X-Ser/Thr sequon is an important determinant of N-linked core glycosylation efficiency. , 1998, Biochemistry.
[20] Hugo Vanderstichele,et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein , 1998, Nature.
[21] R. Doms,et al. Alzheimer's Aβ(1–42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells , 1997, Nature Medicine.
[22] C. Masters,et al. Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides , 1997, Nature Medicine.
[23] R. Doms,et al. Novel β-Secretase Cleavage of β-Amyloid Precursor Protein in the Endoplasmic Reticulum/Intermediate Compartment of NT2N Cells , 1997, The Journal of cell biology.
[24] Mark M. Davis,et al. Ligand-specific oligomerization of T-cell receptor molecules , 1997, Nature.
[25] P. Greengard,et al. Generation of Alzheimer beta-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[26] D. Teplow,et al. Metabolism of the Swedish Amyloid Precursor Protein Variant in Neuro2a (N2a) Cells , 1996, The Journal of Biological Chemistry.
[27] D. Selkoe,et al. The Swedish mutation causes early-onset Alzheimer's disease by β-secretase cleavage within the secretory pathway , 1995, Nature Medicine.
[28] B. Marsh,et al. Molecular regulation of GLUT-4 targeting in 3T3-L1 adipocytes , 1995, The Journal of cell biology.
[29] Joanne I. Yeh,et al. Distinct signals in the GLUT4 glucose transporter for internalization and for targeting to an insulin-responsive compartment , 1995, The Journal of cell biology.
[30] M. Jackson,et al. A Role for Acidic Residues in Di-leucine Motif-based Targeting to the Endocytic Pathway (*) , 1995, The Journal of Biological Chemistry.
[31] O. Bakke,et al. Targeting of membrane proteins to endosomes and lysosomes. , 1994, Trends in cell biology.
[32] S. Squazzo,et al. Evidence that production and release of amyloid beta-protein involves the endocytic pathway. , 1994, The Journal of biological chemistry.
[33] M. Birnbaum,et al. A Leu-Leu sequence is essential for COOH-terminal targeting signal of GLUT4 glucose transporter in fibroblasts. , 1994, The Journal of biological chemistry.
[34] J Alexander,et al. Antigen analogs/MHC complexes as specific T cell receptor antagonists. , 1994, Annual review of immunology.
[35] P. Lansbury,et al. Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? , 1993, Cell.
[36] S. Kornfeld,et al. The cytoplasmic tail of the mannose 6-phosphate/insulin-like growth factor-II receptor has two signals for lysosomal enzyme sorting in the Golgi , 1992, The Journal of cell biology.
[37] G. Griffiths,et al. Differential endocytosis of CD4 in lymphocytic and nonlymphocytic cells , 1991, The Journal of experimental medicine.
[38] T. McGraw,et al. Mutagenesis of the human transferrin receptor: two cytoplasmic phenylalanines are required for efficient internalization and a second- site mutation is capable of reverting an internalization-defective phenotype , 1991, The Journal of cell biology.
[39] F. Maxfield,et al. Human transferrin receptor internalization is partially dependent upon an aromatic amino acid on the cytoplasmic domain. , 1990, Cell regulation.
[40] K. Grzeschik,et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.
[41] G. Glenner,et al. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein , 1984 .
[42] R. Lake. FURTHER CHARACTERIZATION OF THE F1-HISTONE PHOSPHOKINASE OF METAPHASE-ARRESTED ANIMAL CELLS , 1973, The Journal of cell biology.